Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Neurooncol ; 10(3): 247-52, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1895166

RESUMO

Hyperthermia increases the cytotoxicity of the nitrosourea BCNU (carmustine). Glucose given before treatment may further increase the value of thermochemotherapy, presumably by lowering tumour pH through blood flow reduction. The water-soluble ACNU (nimustine) is an alternative to other nitrosoureas in the treatment of gliomas. The drug is soluble without use of ethanol, and the eye complications when given intra-arterially are reduced compared with similar use of BCNU. The influence of simultaneous hyperthermia on treatment with ACNU, and the value of glucose administered before thermochemotherapy therefore were investigated in the malignant rat glioma BT4An. BD IX rats with subcutaneous BT4An tumours on the hind leg were treated with ACNU (i.p.), or ACNU and locally applied waterbath hyperthermia (44 degrees C for 45 min), with or without previous glucose (6 g/kg i.p. 2 hours before treatment). ACNU (10 or 20 mg/kg) alone and ACNU (20 mg/kg) after previous glucose did not influence tumour growth, compared to the controls. Simultaneous ACNU (10 mg/kg) and hyperthermia clearly was more effective than treatment with hyperthermia alone. Glucose load before treatment further enhanced the effect of combined ACNU and hyperthermia. Glucose before treatment did not change local toxicity or weight profiles of treatment with ACNU alone, or simultaneous ACNU and hyperthermia. Glucose load therefore represented a therapeutic gain when administered before thermochemotherapy with ACNU.


Assuntos
Neoplasias Encefálicas , Glioma/terapia , Glucose/administração & dosagem , Hipertermia Induzida , Nimustina/uso terapêutico , Animais , Carmustina/uso terapêutico , Carmustina/toxicidade , Terapia Combinada , Ensaios de Seleção de Medicamentos Antitumorais , Sinergismo Farmacológico , Glioma/tratamento farmacológico , Glucose/farmacologia , Concentração de Íons de Hidrogênio , Soluções Hipertônicas/administração & dosagem , Soluções Hipertônicas/farmacologia , Transplante de Neoplasias , Nimustina/toxicidade , Ratos , Ratos Endogâmicos , Doenças Retinianas/induzido quimicamente , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/terapia , Células Tumorais Cultivadas/transplante
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA